Most Recent “Hospital-Acquired Infections” Published by MarketPublishers.com

LONDON--(BUSINESS WIRE)-- A hospital acquired infection (HAI), also known as a 'nosocomial' infection, is an infection acquired during hospital care which was not present or incubating at the time of admission. Infections which occur more than 48 hours after admission are also considered nosocomial.

Both diagnostics and treatment segments taken together are valued at more than $9 billion for 2010 with 2015 sales expected to reach $10.3 billion. The market has grown by 3% year-on-year, with sales increasing from $7.9 billion in 2005. With the treatment segment struggling to maintain growth, the testing segment is likely to offset declines starting in 2012.

New market research report “Hospital-Acquired Infections: Diagnostic Markets and Testing Developments, Treatments, Key Competitors and Trends” worked out by Kalorama Information focuses mainly on bacterial nosocomial infections with some mention of viral infections. The study features valuable data and information including total size and growth of the market, key issues and trends impacting the sector, provides comparison of molecular testing with conventional testing, offers detailed company profiles and future market forecasts to 2015. The market analysis considers primarily the epidemiological considerations and the size of patient groups both in the United States and globally, where available.

Report Details:

Title: Hospital-Acquired Infections: Diagnostic Markets and Testing Developments, Treatments, Key Competitors and Trends

Published: July, 2011

Pages: 150

Price: US$ 3,995.00

http://marketpublishers.com/report/medicine_pharmaceuticals_biotechnology/equipment_services/hospital_acquired_infections_diagnostic_markets_n_testing_developments_treatments_key_competitors_n_trends.html

Report Contents:

CHAPTER ONE: EXECUTIVE SUMMARY

Overview

Infection Control Summary

Scope and Methodology

Total Size and Growth of the Market

Issues and Trends Affecting Market

Molecular Testing vs. Conventional Testing

Leading Competitors

CHAPTER TWO: INTRODUCTION AND INDUSTRY TRENDS

Overview

Introduction to Pathogens

Classification of Antibacterial Organisms

Common Hospital (nosocomial) Infections

Description of Infections

Acinetobacter Baumannii

Clostridium Difficile

Gastroenteritis

Hospital-Acquired Pneumonia (HAP)

Pseudomonas Aeruginosa

Staphylococcus Aureus/Methicillin-Resistant Staphylococcus Aureus

Stenotrophomonas Maltophilia

Tuberculosis

Urinary Tract Infections

Vancomycin-Resistant Enterococcus

Hospital Units and Infection Risks

Burn Units

Intensive Care Units

Emergency Departments

Principles of Anti-bacterial Therapy

Infecting Organism

Antibiotic Sensitivity Testing

Site of Infection

Host Defenses and Organ Function

Antibiotic Pharmacokinetics

Monitoring Therapy

General Infection Statistics

Nosocomial Infection Statistics

Populations at Risk for Infection

Demographics of the World

Infections and Drug Resistance

Causes of Drug Resistance

Antibiotic Abuse

To order the report or ask for free sample pages, please contact [email protected]



CONTACT:

The Market Publishers, Ltd.
Tanya Rezler
Tel: +44 208 144 6009
Fax: +44 207 900 3970
[email protected]
www.marketpublishers.com

KEYWORDS:   United Kingdom  Europe

INDUSTRY KEYWORDS:   Health  Hospitals  Communications  Marketing  General Health

MEDIA:

Logo
 Logo

Suggested Articles

The profit margins and management of Community Health Group raise questions about oversight of managed care insurers.

Financial experts are warning practices about the pitfalls of promoting medical credit cards to their patients.

A proposed rule issued by HHS on Tuesday would expand short-term coverage, a move Seema Verma said will have "virtually no impact" on ACA premiums.